Tiansheng Pharmaceutical Group Co., Ltd. (002872.SZ)
CNY 3.93
(2.08%)
CNY 3.93
(2.08%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -93.07 Million CNY | -1.66% |
| 2022 | -91.55 Million CNY | -26.56% |
| 2021 | -72.33 Million CNY | 85.34% |
| 2020 | -493.58 Million CNY | -125.44% |
| 2019 | -218.93 Million CNY | -1501.55% |
| 2018 | 15.62 Million CNY | -93.72% |
| 2017 | 248.57 Million CNY | 10.73% |
| 2016 | 224.49 Million CNY | 16.94% |
| 2015 | 191.97 Million CNY | 16.65% |
| 2014 | 164.57 Million CNY | 30.67% |
| 2013 | 125.94 Million CNY | 14.51% |
| 2012 | 109.98 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 6.75 Million CNY | 129.83% |
| 2024 Q1 | -20.46 Million CNY | -81.9% |
| 2024 Q2 | -22.64 Million CNY | -10.68% |
| 2023 Q1 | -15.94 Million CNY | 43.39% |
| 2023 FY | -93.07 Million CNY | -1.66% |
| 2023 Q2 | -34.89 Million CNY | -118.87% |
| 2023 Q3 | -31.04 Million CNY | 11.03% |
| 2023 Q4 | -11.24 Million CNY | 63.76% |
| 2022 Q4 | -28.16 Million CNY | -72.12% |
| 2022 FY | -91.55 Million CNY | -26.56% |
| 2022 Q3 | -16.36 Million CNY | 47.09% |
| 2022 Q2 | -30.92 Million CNY | -92.0% |
| 2022 Q1 | -16.1 Million CNY | -306.54% |
| 2021 Q1 | -25.29 Million CNY | 93.19% |
| 2021 Q4 | -3.96 Million CNY | 85.55% |
| 2021 Q2 | -15.18 Million CNY | 39.98% |
| 2021 FY | -72.33 Million CNY | 85.34% |
| 2021 Q3 | -27.41 Million CNY | -80.57% |
| 2020 Q2 | -59.9 Million CNY | -597.66% |
| 2020 FY | -493.58 Million CNY | -125.44% |
| 2020 Q4 | -371.42 Million CNY | -631.0% |
| 2020 Q3 | -50.81 Million CNY | 15.18% |
| 2020 Q1 | -8.58 Million CNY | 94.6% |
| 2019 Q4 | -159.01 Million CNY | -128.74% |
| 2019 Q3 | -69.51 Million CNY | -1364.9% |
| 2019 Q2 | -4.74 Million CNY | -145.04% |
| 2019 Q1 | 10.53 Million CNY | 130.8% |
| 2019 FY | -218.93 Million CNY | -1501.55% |
| 2018 Q2 | 43.29 Million CNY | -34.62% |
| 2018 Q3 | 35.43 Million CNY | -18.17% |
| 2018 Q4 | -34.2 Million CNY | -196.53% |
| 2018 FY | 15.62 Million CNY | -93.72% |
| 2018 Q1 | 66.22 Million CNY | -25.7% |
| 2017 Q1 | 55.8 Million CNY | -32.14% |
| 2017 FY | 248.57 Million CNY | 10.73% |
| 2017 Q4 | 89.12 Million CNY | 54.77% |
| 2017 Q3 | 57.58 Million CNY | 25.51% |
| 2017 Q2 | 45.87 Million CNY | -17.78% |
| 2016 Q3 | 51.75 Million CNY | 24.1% |
| 2016 FY | 224.49 Million CNY | 16.94% |
| 2016 Q4 | 82.23 Million CNY | 58.89% |
| 2016 Q2 | 41.7 Million CNY | -14.55% |
| 2016 Q1 | 48.8 Million CNY | 0.0% |
| 2015 FY | 191.97 Million CNY | 16.65% |
| 2014 FY | 164.57 Million CNY | 30.67% |
| 2013 FY | 125.94 Million CNY | 14.51% |
| 2012 FY | 109.98 Million CNY | 0.0% |